Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry)

Mostrar otras versiones (1)

AIMS: Epidemiological surveillance has raised safety concerns for mRNA SARS-CoV-2-vaccination-related myocarditis. We aimed to analyze epidemiological, clinical and imaging findings associated with clinical outcomes in these patients in an international multi-center registry (NCT05268458). METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroth, Daniel, Garg, Ria, Bocova, Xhoi, Hansmann, Jochen, Haass, Markus, Yan, Andrew, Fernando, Carlos, Chacko, Binita, Oikonomou, Anastasia, White, James, Alhussein, Muhammad Mustafa, Giusca, Sorin, Ochs, Andreas, Korosoglou, Grigorios, André, Florian, Friedrich, Matthias G., Ochs, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321411/
https://www.ncbi.nlm.nih.gov/pubmed/37416926
http://dx.doi.org/10.3389/fcvm.2023.1204232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321411/
https://www.ncbi.nlm.nih.gov/pubmed/37416926
http://dx.doi.org/10.3389/fcvm.2023.1204232

Ejemplares similares